Complex considerations - Fever and pancytopenia after solid organ transplantation.
hemophagocytic lymphohistiocytosis
solid organ transplantation
toxoplasmosis
Journal
Transplant infectious disease : an official journal of the Transplantation Society
ISSN: 1399-3062
Titre abrégé: Transpl Infect Dis
Pays: Denmark
ID NLM: 100883688
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
revised:
29
05
2023
received:
11
05
2023
accepted:
13
05
2023
medline:
15
8
2023
pubmed:
6
6
2023
entrez:
6
6
2023
Statut:
ppublish
Résumé
This case describes a 42-year-old man who underwent kidney transplantation and developed fevers, pancytopenia, and elevated liver function tests starting on post-operative day 9. An extensive microbiologic and molecular workup was performed, ultimately leading to a diagnosis of donor-derived toxoplasmosis with associated hemophagocytic lymphohistiocytosis in the recipient. This case highlights the potential for post-transplant toxoplasmosis in high-risk mismatch (D+/R-) recipients, as well as the role of Toxoplasma-targeted prophylaxis in such patients.
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14079Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Valdes Franci E, Perez Flores I, Candel FJ, et al. Hemophagocytic syndrome triggered by donor-transmitted toxoplasmosis as a complication in same-donor recipients of renal transplantation: Case report and review of the literature. Transpl Infect Dis. 2021;23:e13732.
Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007;357:2601-2614.
Wolfe CR, Ison MG, Practice ASTIDCo. Donor-derived infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13547.
Clemente WT, Faria LC, Cota GF, et al. Donor-Derived Tuberculosis: A Case Report and the Role of Communication Gaps in Transplantation Safety. Case Rep Transplant. 2021;2021:8816426.
Kay A, Barry PM, Annambhotla P, et al. Solid organ transplant-transmitted tuberculosis linked to a community outbreak - California, 2015. MMWR Morb Mortal Wkly Rep. 2017;66:801-805.
George MR. Hemophagocytic lymphohistiocytosis: Review of etiologies and management. J Blood Med. 2014;5:69-86.
Dhote R, Simon J, Papo T, et al. Reactive hemophagocytic syndrome in adult systemic disease: Report of twenty-six cases and literature review. Arthritis Rheum. 2003;49:633-639.
Al-Samkari H, Berliner N. Hemophagocytic lymphohistiocytosis. Annu Rev Pathol. 2018;13:27-49.
La Rosee P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133:2465-2477.
Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol. 2020;34:101515.
Weitzman S. Approach to hemophagocytic syndromes. Hematology Am Soc Hematol Educ Program. 2011;2011:178-183.
Chesner J, Schiano TD, Fiel MI, Crismale JF. Hemophagocytic lymphohistiocytosis occurring after liver transplantation: A case series and review of the literature. Clin Transplant. 2021;35:e14392.
Nusshag C, Morath C, Zeier M, Weigand MA, Merle U, Brenner T. Hemophagocytic lymphohistiocytosis in an adult kidney transplant recipient successfully treated by plasmapheresis: A case report and review of the literature. Medicine (Baltimore). 2017;96:e9283.
Hattori N, Sato M, Uesugi Y, et al. Characteristics and predictors of post-transplant-associated hemophagocytic lymphohistiocytosis in adults. Int J Hematol. 2021;113:693-702.
Fernandez-Sabe N, Cervera C, Farinas MC, et al. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study. Clin Infect Dis. 2012;54:355-361.
UNOS. Guidance regarding donor Toxoplasma screening and organ acceptance. 2017. Accessed June 22, 2022. https://unos.org/news/guidance-regarding-donor-toxoplasma-screening-and-organ-acceptance/
Adekunle RO, Sherman A, Spicer JO, et al. Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers. Transpl Infect Dis. 2021;23:e13636.